TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32669051

Group type: EXPERIMENTAL
Intervention: 1RMMVT (minimal velocity threshold)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1RMLD0 (load at zero velocity)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1RMFV (force-velocity)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Free-weight exercises
Number of subjects: 20

Group type: COMPARATOR
Intervention: 7-load predictions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1RMMVT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Smith machine exercises
Number of subjects: 20

Group type: COMPARATOR
Intervention: Free-weight squat and overhead press predictions
Number of subjects: 20
Study: 34355250

Group type: EXPERIMENTAL
Intervention: ABP 980 (6 mg/kg) plus pertuzumab (420 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Trastuzumab RP (6 mg/kg) plus pertuzumab (420 mg)
Number of subjects: 36
Study: 32645830

Group type: EXPERIMENTAL
Intervention: Short Foot Exercise (SFE) training
Number of subjects: 85

Group type: COMPARATOR
Intervention: Non-Biomechanical Function (NBF) exercise
Number of subjects: 85
Study: 35073366

Group type: EXPERIMENTAL
Intervention: FES row training (FESRT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 31
Study: 33325403

Group type: EXPERIMENTAL
Intervention: LUS guided RM
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-ultrasound guided RM
Number of subjects: 44
Study: 35306390

Group type: EXPERIMENTAL
Intervention: DAA treatment with BDI-II scores ≥ 18 at baseline
Number of subjects: 150

Group type: COMPARATOR
Intervention: DAA treatment with BDI-II scores < 18 at baseline
Number of subjects: 150
Study: 34457094

Group type: EXPERIMENTAL
Intervention: Pharmacist-led care (patient education and phone calls)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Pharmacist-led care
Number of subjects: 108
Study: 32936233

Group type: EXPERIMENTAL
Intervention: Worst Itch Numeric Rating Scale (WI‐NRS)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Average Itch Numeric Rating Scale (AI‐NRS)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Itch Numeric Rating Scale (NRS) items
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Worst Itch Visual Analog Scale (WI‐VAS)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Electronic Verbal Rating Scale (eVRS) for itch severity
Number of subjects: 123
Study: 32553498

Group type: EXPERIMENTAL
Intervention: Proprioceptive Elastic Method (PROEL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard perioperative rehabilitation
Number of subjects: 15
Study: 32487263

Group type: EXPERIMENTAL
Intervention: C-reactive protein-based protocol (CRP)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Best practices for rational use of antibiotics (Control)
Number of subjects: 130
Study: 35044504

Group type: EXPERIMENTAL
Intervention: High-dose Lycium barbarum (20 g, containing 20 mg of zeaxanthin and 2 mg of lutein)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Low-dose Lycium barbarum (10 g, containing 10 mg of zeaxanthin and 1 mg of lutein)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Low-dose control (1 mg of lutein)
Number of subjects: 54

Group type: COMPARATOR
Intervention: High-dose control (2 mg of lutein)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Blank control
Number of subjects: 54
Study: 33905971

Group type: EXPERIMENTAL
Intervention: Ecological Momentary Assessment (EMA) adherence
Number of subjects: 110
Study: 34049283

Group type: EXPERIMENTAL
Intervention: Patient-specific template-guided (TG) pedicle screw insertion
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard freehand (FH) pedicle screw insertion
Number of subjects: 24
Study: 35085177

Group type: EXPERIMENTAL
Intervention: Phase change material liners
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional liners
Number of subjects: 42
Study: 33128725

Group type: EXPERIMENTAL
Intervention: Ankylosing Spondylitis Quality of Life (ASQoL) scale
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Psychometric assessment methods (exploratory factor analysis, item response theory)
Number of subjects: 325
Study: 32202814

Group type: EXPERIMENTAL
Intervention: Supportive‐expressive (SE) psychodynamic treatment
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Proposed clinical model for resolution of alliance ruptures
Number of subjects: 1
Study: 32308012

Group type: EXPERIMENTAL
Intervention: ACT-Plan
Number of subjects: 358
Study: 35334900

Group type: EXPERIMENTAL
Intervention: Cow milk formula (CMF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isocaloric extensive protein hydrolysate formula (EHF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: EHF
Number of subjects: 30
Study: 34503565

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Tianshu (ST25)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zusanli (ST36)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no electroacupuncture)
Number of subjects: 105
Study: 35062752

Group type: EXPERIMENTAL
Intervention: Standard three-dose (SD) Hepatitis B vaccine
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Double three-dose (DD) Hepatitis B vaccine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Both SD and DD
Number of subjects: 61
Study: 33784233

Group type: EXPERIMENTAL
Intervention: Higher CI‐6MW
Number of subjects: 477

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 477
Study: 36194605

Group type: EXPERIMENTAL
Intervention: COPD participants (study group)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Older adults without respiratory conditions (control group)
Number of subjects: 138
Study: 33618392

Group type: EXPERIMENTAL
Intervention: Isometric biceps exercise (4×1 min at 30% of 1‐RM, 2 min recovery)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control session (without exercise)
Number of subjects: 12
Study: 32827348

Group type: EXPERIMENTAL
Intervention: Lurasidone 20-60 mg/day
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Lurasidone 80-120 mg/day
Number of subjects: 525

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 525
Study: 34331755

Group type: EXPERIMENTAL
Intervention: Osteopathic manual therapy (OMT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Kaltenborn-Evjenth orthopedic manual therapy (KEOMT)
Number of subjects: 68
Study: 34420366

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI (n=388)
Number of subjects: 1171

Group type: COMPARATOR
Intervention: No PCI (n=198)
Number of subjects: 1171
Study: 34373566

Group type: EXPERIMENTAL
Intervention: TroponinT levels at admission
Number of subjects: 105
Study: 32443329

Group type: EXPERIMENTAL
Intervention: TMP-SMX plus azithromycin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Synergistic sulfonamides plus clindamycin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 34991746

Group type: EXPERIMENTAL
Intervention: Provox XtraFlow
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Provox Luna
Number of subjects: 28
Study: 34078289

Group type: EXPERIMENTAL
Intervention: Strength intervention group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endurance intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no regular exercise)
Number of subjects: 0
Study: 32193889

Group type: EXPERIMENTAL
Intervention: Clinical-CT index (AUC, 0.81)
Number of subjects: 2218

Group type: EXPERIMENTAL
Intervention: Clinical-CT index cutoff ≥ 46
Number of subjects: 2218

Group type: EXPERIMENTAL
Intervention: Clinical-CT index cutoff ≥ 56.5
Number of subjects: 2218
Study: 34181195

Group type: EXPERIMENTAL
Intervention: Single-course methotrexate (MTX)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Single-course methotrexate + dactinomycin (ACTD)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Multi-course methotrexate (control arm)
Number of subjects: 276
Study: 34212917

Group type: EXPERIMENTAL
Intervention: HPLT + Glucosamine sulfate 1500mg (GS - Dona®)
Number of subjects: 90

Group type: COMPARATOR
Intervention: HPLT + placebo
Number of subjects: 90
Study: 32718783

Group type: EXPERIMENTAL
Intervention: Peer-led lifestyle intervention
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 292
Study: 35238704

Group type: EXPERIMENTAL
Intervention: Standard del Nido cardioplegia solution (SDN)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Modified del Nido cardioplegia solution (MDN)
Number of subjects: 80
Study: 33397862

Group type: EXPERIMENTAL
Intervention: Video Laryngoscope (VL)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Direct Laryngoscope (DL)
Number of subjects: 146
Study: 32433753

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 2g temocillin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of 2g temocillin
Number of subjects: 8
Study: 35716425

Group type: COMPARATOR
Intervention: Indeterminate stress ECG during exercise imaging stress test (EIST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Discordant stress ECG during exercise imaging stress test (EIST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indeterminate stress ECG during vasodilator nuclear stress test (PIST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Discordant stress ECG during vasodilator nuclear stress test (PIST)
Number of subjects: 0
Study: 33241757

Group type: EXPERIMENTAL
Intervention: Sparing of puboprostatic ligaments (PPLs) during laparoscopic radical prostatectomy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Division of puboprostatic ligaments (PPLs) during laparoscopic radical prostatectomy
Number of subjects: 74
Study: 33847758

Group type: EXPERIMENTAL
Intervention: COBMINDEX
Number of subjects: 116

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 116
Study: 32090996

Group type: EXPERIMENTAL
Intervention: 3D laser scanner (3DLS) and tablet computer for digitally assisted BCRL assessment
Number of subjects: 0
Study: 35357402

Group type: EXPERIMENTAL
Intervention: Highly aspherical lenslets (HAL)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Slightly aspherical lenslets (SAL)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Single-vision spectacle lenses (SVL)
Number of subjects: 157
Study: 34566523

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/day plus rosuvastatin 20 mg/day (combination group)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Rosuvastatin 20 mg/day (rosuvastatin group)
Number of subjects: 171
Study: 32433648

Group type: EXPERIMENTAL
Intervention: Volar locking plate
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Highly active participants
Number of subjects: 304

Group type: COMPARATOR
Intervention: Casting (Control)
Number of subjects: 304
Study: 34818966

Group type: EXPERIMENTAL
Intervention: Polyurethane foam dressing
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 110
Study: 34478869

Group type: EXPERIMENTAL
Intervention: CHATO education (n = 64)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (n = 64)
Number of subjects: 128
Study: 35753872

Group type: COMPARATOR
Intervention: Detuned laser (placebo)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Manual therapy (active)
Number of subjects: 30
Study: 34310400

Group type: EXPERIMENTAL
Intervention: 10 μg V-01 (two-dose regimen)
Number of subjects: 880

Group type: EXPERIMENTAL
Intervention: 25 μg V-01 (two-dose regimen)
Number of subjects: 880

Group type: EXPERIMENTAL
Intervention: 50 μg V-01 (one-dose regimen)
Number of subjects: 880

Group type: EXPERIMENTAL
Intervention: V-01 (both regimens)
Number of subjects: 880

Group type: COMPARATOR
Intervention: Placebo (two-dose regimen)
Number of subjects: 880

Group type: COMPARATOR
Intervention: Placebo (one-dose regimen)
Number of subjects: 880
Study: 32769506

Group type: EXPERIMENTAL
Intervention: Fluid intake group (allowed to drink up to 400 ml of apple juice for 90 minutes after randomisation)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Fasting group (nil by mouth)
Number of subjects: 125
Study: 34044246

Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP)
Number of subjects: 970

Group type: COMPARATOR
Intervention: ICD-10
Number of subjects: 970
Study: 32660769

Group type: EXPERIMENTAL
Intervention: MSB11455 (6 mg/0.6 mL)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Reference Pegfilgrastim (Neulasta) (6 mg/0.6 mL)
Number of subjects: 292
Study: 36395190

Group type: EXPERIMENTAL
Intervention: Internal and external (visual, auditory, tactile) cues during walking tasks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Baseline walking without cues
Number of subjects: 80
Study: 34310489

Group type: EXPERIMENTAL
Intervention: Activities Completed over Time in 24 Hours (ACT24) previous day recalls
Number of subjects: 2640

Group type: EXPERIMENTAL
Intervention: Leisure time sedentary behavior
Number of subjects: 2640
Study: 33087083

Group type: EXPERIMENTAL
Intervention: Individual financial incentives (IND)
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Group financial incentives (GRP)
Number of subjects: 847

Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 847
Study: 34498320

Group type: EXPERIMENTAL
Intervention: Adapted soccer programme (twice a week for 16 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (usual daily regime)
Number of subjects: 25
Study: 33962594

Group type: EXPERIMENTAL
Intervention: Group A: One additional dose of 1g IV‐TXA 3 hours postoperatively
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Group B: Three doses of 1g IV‐TXA at 3, 6, and 12 hours postoperatively
Number of subjects: 97

Group type: COMPARATOR
Intervention: Group A
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 97
Study: 35914916

Group type: EXPERIMENTAL
Intervention: Prophylactic surgery plus HIPEC CO2 with mitomycin
Number of subjects: 388

Group type: COMPARATOR
Intervention: Standard surgery
Number of subjects: 388
Study: 33742418

Group type: EXPERIMENTAL
Intervention: Computer vision algorithm
Number of subjects: 7

Group type: COMPARATOR
Intervention: Manual annotation by human annotators
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both manual annotation and computer vision algorithm
Number of subjects: 7
Study: 32347885

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 27564
Study: 36067589

Group type: EXPERIMENTAL
Intervention: 28 g/d of dry roasted, unsalted peanuts for 6 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isocaloric lower-fat higher-carbohydrate (LFHC) snack for 6 weeks
Number of subjects: 50
Study: 33825414

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at both Zusanli (ST36) and Zhongwan (CV12)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Electroacupuncture at Zhongwan (CV12) alone
Number of subjects: 65
Study: 36205248

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg daily for 45 days
Number of subjects: 10000
Study: 33829580

Group type: EXPERIMENTAL
Intervention: Anti-PD-1/PD-L1 inhibitors (nivolumab, pembrolizumab, or atezolizumab)
Number of subjects: 249
Study: 32878758

Group type: EXPERIMENTAL
Intervention: Preoperative endoscopic injection of botulinum toxin (BTX) into the sphincter of Oddi
Number of subjects: 60

Group type: COMPARATOR
Intervention: No preoperative endoscopy (Control)
Number of subjects: 60
Study: 35894971

Group type: EXPERIMENTAL
Intervention: Familias Unidas for Health and Wellness (FUHW)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control
Number of subjects: 280
Study: 34820909

Group type: EXPERIMENTAL
Intervention: 550 mg/d supplemental choline (as choline chloride)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 25 mg/d d9-choline (control)
Number of subjects: 0
Study: 34630560

Group type: EXPERIMENTAL
Intervention: Associated Mirror Therapy (AMT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bimanual training without mirroring (Control Group)
Number of subjects: 36
Study: 33003179

Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline
Number of subjects: 57

Group type: COMPARATOR
Intervention: 20% mannitol
Number of subjects: 57
Study: 34182189

Group type: EXPERIMENTAL
Intervention: 6-hour urine protein collection
Number of subjects: 115

Group type: COMPARATOR
Intervention: 24-hour urine protein collection
Number of subjects: 115
Study: 32461554

Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice-daily for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33090614

Group type: EXPERIMENTAL
Intervention: Primary resistance to clarithromycin
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Primary resistance to levofloxacin
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Primary resistance to metronidazole
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Secondary resistance to clarithromycin
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Secondary resistance to levofloxacin
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Secondary resistance to metronidazole
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Resistance to amoxicillin
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Resistance to tetracycline
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Resistance to rifampicin
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Primary resistance to clarithromycin (2014-2016 comparison)
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Primary levofloxacin resistance (stability)
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Metronidazole resistance (trend)
Number of subjects: 951
Study: 32657194

Group type: EXPERIMENTAL
Intervention: Exercise intervention (n = 24, adhered n = 9)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 42
Study: 35839545

Group type: EXPERIMENTAL
Intervention: Personalized diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 100
Study: 34147151

Group type: EXPERIMENTAL
Intervention: Upadacitinib in combination with topical corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32888031

Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg)
Number of subjects: 545
Study: 36266767

Group type: EXPERIMENTAL
Intervention: Peer charity donation intervention
Number of subjects: 420
Study: 34876098

Group type: EXPERIMENTAL
Intervention: Titanium brush (TiB)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash (CHX)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Brush-acid
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Brush-laser
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Citric acid (CA)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Negative control (PBS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No-treatment group
Number of subjects: 75
Study: 33525489

Group type: EXPERIMENTAL
Intervention: 4-week Starch- and Sucrose-Reduced Diet (SSRD), n = 80
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (habitual diet), n = 25
Number of subjects: 105
Study: 33560659

Group type: EXPERIMENTAL
Intervention: Ketamine (0.25 mg·kg‐1 bolus followed by 5 µg·kg‐1·min‐1 infusion for up to 45 minutes)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60
Study: 32848185

Group type: EXPERIMENTAL
Intervention: Intravenous iron supplementation (800 mg iron-carboxymaltose)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study: 35807068

Group type: EXPERIMENTAL
Intervention: High-power diode laser
Number of subjects: 57

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 57
Study: 32636290

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 40
Study: 34534565

Group type: EXPERIMENTAL
Intervention: Repeat resection
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard care with no repeat resection
Number of subjects: 250
Study: 32886778

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Single-session sleep hygiene (SH)
Number of subjects: 56
Study: 33337237

Group type: EXPERIMENTAL
Intervention: P. foliicola spore suspension (1.0 × 10^6/ml) applied to three-week-old seedlings of mung bean cultivar 'Jilv 7' (n=5)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sterile water (control group, n=3)
Number of subjects: 10
Study: 32969088

Group type: EXPERIMENTAL
Intervention: Video consultations combined with regular outpatient care
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 240
Study: 34575354

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (6 months)
Number of subjects: 289
Study: 35793222

Group type: EXPERIMENTAL
Intervention: RBOP2 design
Number of subjects: 0
Study: 33161523

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (primary wound closure)
Number of subjects: 71
Study: 32213737

Group type: EXPERIMENTAL
Intervention: Absorb BVS
Number of subjects: 400

Group type: COMPARATOR
Intervention: XIENCE (DES)
Number of subjects: 400
Study: 35940768

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich diet
Number of subjects: 51
Study: 34869187

Group type: EXPERIMENTAL
Intervention: SINEMA intervention
Number of subjects: 637
Study: 33403333

Group type: EXPERIMENTAL
Intervention: Glass fibre post (GFP) with Z350 resin composite core
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pre‐fabricated metal post (PMP) with Z350 resin composite core
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cast metal core (CMC) with silver‐tin alloy
Number of subjects: 60
Study: 36125701

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg QD
Number of subjects: 3117

Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg QD
Number of subjects: 3117

Group type: EXPERIMENTAL
Intervention: Upadacitinib (15 mg or 30 mg QD)
Number of subjects: 3117

Group type: EXPERIMENTAL
Intervention: RAPID3 scores
Number of subjects: 3117
Study: 33853797

Group type: EXPERIMENTAL
Intervention: Hydrophobic PICC (with pressure-activated valve)
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate-impregnated PICC (with external clamp)
Number of subjects: 1098

Group type: COMPARATOR
Intervention: Conventional polyurethane PICC (with external clamp)
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 1098